Does serelaxin treatment alter passive mechanical wall properties in small resistance arteries?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Microcirculation

• Publication date

  2016-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/micc.12321PMID 27653183
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Time‐dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin)

  2016cited by this paper
• Differential effects of relaxin deficiency on vascular aging in arteries of male mice

  2015cited by this paper
• Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice.

  2015cited by this paper
• Conditioned Sounds Enhance Visual Processing

  2014cited by this paper
• Therapeutic effects of serelaxin in acute heart failure.

  2014cited by this paper
• A Vasoactive Role for Endogenous Relaxin in Mesenteric Arteries of Male Mice

  2014cited by this paper
• Recombinant Human Relaxin-2: (How) Can a Pregnancy Hormone Save Lives in Acute Heart Failure?

  2014cited by this paper
• Localization of relaxin receptors in arteries and veins, and region‐specific increases in compliance and bradykinin‐mediated relaxation after in vivo serelaxin treatment

  2014cited by this paper
• Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension

  2013cited by this paper
• A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure

  2013cited by this paper
• Impaired effect of relaxin on vasoconstrictor reactivity in spontaneous hypertensive rats.

  2013cited by this paper
• A randomized, placebo-controlled clinical trial on the effects of recombinant human relaxin on tooth movement and short-term stability.

  2012cited by this paper
• Arterial stiffening: Causes and consequences

  2012cited by this paper
• Impaired vascular responses to relaxin in diet-induced overweight female rats.

  2012cited by this paper
• Relaxin mediates uterine artery compliance during pregnancy and increases uterine blood flow

  2012cited by this paper
• Relaxin causes selective outward remodeling of brain parenchymal arterioles via activation of peroxisome proliferator‐activated receptor‐γ

  2011cited by this paper
• Relaxin regulates vascular wall remodeling and passive mechanical properties in mice.

  2011cited by this paper
• Aging attenuates the vasodilator response to relaxin.

  2011cited by this paper
• Relaxin Ameliorates Hypertension and Increases Nitric Oxide Metabolite Excretion in Angiotensin II But Not N&ohgr;-Nitro-L-Arginine Methyl Ester Hypertensive Rats

  2011cited by this paper
• Vascular aging: From molecular mechanism to clinical significance

  2010cited by this paper
• Relaxin Therapy Reverses Large Artery Remodeling and Improves Arterial Compliance in Senescent Spontaneously Hypertensive Rats

  2010cited by this paper
• Unveiling the vasodilatory actions and mechanisms of relaxin.

  2010cited by this paper
• Clinical profile of relaxin, a possible new drug for human use.

  2009cited by this paper
• Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.

  2009cited by this paper
• Relaxin family peptide receptors--from orphans to therapeutic targets.

  2008cited by this paper
• Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin.

  2007cited by this paper
• Relaxin in cardiovascular and renal disease.

  2006cited by this paper
• Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats.

  2006cited by this paper
• Relaxin Increases Cardiac Output and Reduces Systemic Arterial Load in Hypertensive Rats

  2005cited by this paper
• Acute and chronic effects of relaxin on vasoactivity, myogenic reactivity and compliance of the rat mesenteric arterial and venous vasculature.

  2005cited by this paper
• Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response.

  2005cited by this paper
• Relaxin's physiological roles and other diverse actions.

  2004cited by this paper
• Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats.

  2004cited by this paper
• Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats.

  2003cited by this paper
• Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype.

  2003cited by this paper
• Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats.

  2002cited by this paper
• Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment

  1999cited by this paper
• Relaxin is a potent renal vasodilator in conscious rats.

  1999cited by this paper
• Relaxin‐induced increased coronary flow through stimulation of nitric oxide production

  1995cited by this paper
• Quantification of Intestinal Microvascular Growth During Maturation: Techniques and Observations

  1987cited by this paper
• Chronic decrease of blood pressure by rat relaxin in spontaneously hypertensive rats.

  1985cited by this paper
• The FASEB Journal • Research Communication Evidence for local relaxin ligand-receptor expression and function in arteries

  year unknowncited by this paper
• Published online in Wiley InterScience (www.interscience.wiley.com) DOI: 10.1002/path.2101 Review Article

  year unknowncited by this paper

• Differential distribution of cholesterol pools across arteries under high-cholesterol diet.

  2022cites this paper
• Peptide hormone relaxin: from molecular effects to clinical results

  2021cites this paper
• The effect of cardiovascular diseases on resistance vasculature and the efficacy of different treatments

  2019cites this paper
• From pregnancy to cardiovascular disease: Lessons from relaxin‐deficient animals to understand relaxin actions in the vascular system

  2018cites this paper
• Peptide hormone relaxin: from bench to bedside.

  2018cites this paper
• Short‐term (48 hours) intravenous serelaxin infusion has no effect on myogenic tone or vascular remodeling in rat mesenteric arteries

  2017cites this paper
• Small artery mechanobiology: Roles of cellular and non‐cellular elements

  2016cites this paper